Kookjeon Pharmaceutical Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 26, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	120,659	168,844	172,478	306,192	324,839	537,308
Market Cap Growth	-45.55%	-2.11%	-43.67%	-5.74%	-39.54%	-
Enterprise Value	131,696	189,611	178,557	319,290	284,635	-
Last Close Price	2235.00	3365.00	3515.00	6222.17	6590.26	10900.81
PE Ratio	-	-	99.34	63.47	36.30	133.06
PS Ratio	0.95	1.29	1.26	2.51	3.13	6.30
PB Ratio	1.12	1.76	1.77	3.14	3.52	6.46
P/TBV Ratio	1.15	1.78	1.80	3.22	3.60	6.50
P/FCF Ratio	26.65	22.53	82.14	-	-	-
P/OCF Ratio	14.29	15.92	17.31	-	-	176.63
EV/Sales Ratio	1.03	1.45	1.31	2.62	2.75	-
EV/EBITDA Ratio	25.23	71.19	32.63	33.11	57.72	-
EV/EBIT Ratio	-	-	486.92	49.05	81.60	-
EV/FCF Ratio	29.09	25.30	85.04	-	-	-
Debt / Equity Ratio	0.37	0.48	0.67	0.81	0.64	0.09
Debt / EBITDA Ratio	7.68	17.23	11.94	8.17	12.03	1.09
Debt / FCF Ratio	8.88	6.13	31.11	-	-	-
Net Debt / Equity Ratio	0.09	0.16	0.19	0.14	-0.39	-0.38
Net Debt / EBITDA Ratio	1.87	5.77	3.38	1.45	-7.22	-4.35
Net Debt / FCF Ratio	2.17	2.05	8.81	-0.31	1.22	4.26
Asset Turnover	0.64	0.67	0.62	0.58	0.68	-
Inventory Turnover	4.40	5.02	4.22	4.05	4.62	-
Quick Ratio	0.91	0.82	0.85	0.94	1.67	2.72
Current Ratio	1.32	1.13	1.19	1.24	2.02	3.52
Return on Equity (ROE)	-7.91%	-4.98%	0.55%	4.95%	10.12%	-
Return on Assets (ROA)	-0.00%	-0.82%	0.10%	1.93%	1.44%	-
Return on Invested Capital (ROIC)	-0.01%	-2.26%	0.20%	7.75%	5.15%	9.38%
Return on Capital Employed (ROCE)	0.00%	-2.30%	0.30%	5.20%	2.80%	7.20%
Earnings Yield	-6.51%	-2.55%	1.01%	1.58%	2.76%	0.75%
FCF Yield	3.75%	4.44%	1.22%	-14.46%	-9.02%	-1.37%
Payout Ratio	-	-	28.26%	-	5.48%	-
Buyback Yield / Dilution	-1.15%	-0.51%	-1.09%	4.23%	-16.16%	-